277 related articles for article (PubMed ID: 21521019)
1. Diagnostics and personalized medicine: observations from the World Companion Diagnostics Summit.
Curran ME; Platero S
Pharmacogenomics; 2011 Apr; 12(4):465-70. PubMed ID: 21521019
[TBL] [Abstract][Full Text] [Related]
2. Four decades of modern pharmacogenomics: from promise to clinical utility. World PGX Summit 2011. Boston, USA, 26-27 April, 2011.
Groenen PM
Pharmacogenomics; 2011 Sep; 12(9):1249-52. PubMed ID: 21919603
[TBL] [Abstract][Full Text] [Related]
3. A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genome-era pathology, precision diagnostics, and preemptive care: a stakeholder summit.
Tonellato PJ; Crawford JM; Boguski MS; Saffitz JE
Am J Clin Pathol; 2011 May; 135(5):668-72. PubMed ID: 21502420
[No Abstract] [Full Text] [Related]
4. Companion diagnostics: the next step in personalized clinical care.
Thongkham D; Terry SF
Genet Test Mol Biomarkers; 2012 Oct; 16(10):1155-6. PubMed ID: 23057592
[No Abstract] [Full Text] [Related]
5. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
Tazawa Y
Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
[TBL] [Abstract][Full Text] [Related]
6. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
7. Companion diagnostics: a regulatory perspective from the last 5 years of molecular companion diagnostic approvals.
Roscoe DM; Hu YF; Philip R
Expert Rev Mol Diagn; 2015; 15(7):869-80. PubMed ID: 26109316
[TBL] [Abstract][Full Text] [Related]
8. Personalized cancer medicine and the future of pathology.
Moch H; Blank PR; Dietel M; Elmberger G; Kerr KM; Palacios J; Penault-Llorca F; Rossi G; Szucs TD
Virchows Arch; 2012 Jan; 460(1):3-8. PubMed ID: 22143935
[TBL] [Abstract][Full Text] [Related]
9. [Discussing the usefulness of companion diagnostics - introductory remarks by chairpersons].
Nobori T; Nomura F
Rinsho Byori; 2014 Dec; 62(12):1263-4. PubMed ID: 25823244
[TBL] [Abstract][Full Text] [Related]
10. Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
Di Sanzo M; Cipolloni L; Borro M; La Russa R; Santurro A; Scopetti M; Simmaco M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):194-203. PubMed ID: 28240172
[TBL] [Abstract][Full Text] [Related]
11. Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.
Morand du Puch CB; Vanderstraete M; Giraud S; Lautrette C; Christou N; Mathonnet M
Theranostics; 2021; 11(19):9538-9556. PubMed ID: 34646385
[TBL] [Abstract][Full Text] [Related]
12. [Companion diagnostics - the future of modern medicine?].
Versicherungsmedizin; 2014 Mar; 66(1):42-3. PubMed ID: 24683900
[No Abstract] [Full Text] [Related]
13. Personalized medicine, pharmacogenomic and companion biomarker.
Manceau H; Amrani K; Peoc'h K
Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
Donovan MJ; Cordon-Cardo C
Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing for cancer drug development: the present and visions for the future.
Kahn SM
Per Med; 2014 Mar; 11(2):139-142. PubMed ID: 29751374
[TBL] [Abstract][Full Text] [Related]
16. Companion and Complementary Diagnostics: Clinical and Regulatory Perspectives.
Jørgensen JT
Trends Cancer; 2016 Dec; 2(12):706-712. PubMed ID: 28741518
[TBL] [Abstract][Full Text] [Related]
17. Update on molecular companion diagnostics - a future in personalized medicine beyond Sanger sequencing.
Campbell MR
Expert Rev Mol Diagn; 2020 Jun; 20(6):637-644. PubMed ID: 32167388
[TBL] [Abstract][Full Text] [Related]
18. [Personalized urooncology based on molecular uropathology: what is the future?].
Dahl E; Haller F
Urologe A; 2013 Jul; 52(7):976-81. PubMed ID: 23831986
[TBL] [Abstract][Full Text] [Related]
19. Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations.
Thomford NE; Dzobo K; Chimusa E; Andrae-Marobela K; Chirikure S; Wonkam A; Dandara C
OMICS; 2018 Jun; 22(6):375-391. PubMed ID: 29927715
[TBL] [Abstract][Full Text] [Related]
20. Intellectual property considerations for molecular diagnostic development with emphasis on companion diagnostics.
Glorikian H; Warburg RJ; Moore K; Malinowski J
Expert Opin Ther Pat; 2018 Feb; 28(2):123-128. PubMed ID: 29224409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
